A combination of two previously studied osteoarthritis drugs reverses arthritis in rats

The top image shows a knee joint in a healthy rat. (White indicates cartilage.) The second image from top shows a joint with grade 2 untreated osteoarthritis. The third image shows a joint with osteoarthritis that has worsened from grade 2 to grade 4 after six weeks of placebo therapy. The bottom image shows a joint with osteoarthritis that improved from grade 2 to grade 1 (mild) after six weeks of combination therapy with alphaKlotho and sTGFbR2.

Credit: Salk Institute

Article Highlights

People with osteoarthritis, or “wear and tear” arthritis, have limited treatment options: pain relievers or joint replacement surgery. Now, Salk researchers have discovered that a powerful combination of two experimental drugs reverses the cellular and molecular signs of osteoarthritis in rats as well as in isolated human cartilage cells
“What’s really exciting is that this is potentially a therapy that can be translated to the clinic quite easily,” says Juan Carlos Izpisua Belmonte, lead author and a professor in Salk’s Gene Expression Laboratory. “We are excited to continue refining this promising combination therapy for human use.”
Affecting 30 million adults, osteoarthritis is the most common joint disorder in the United States and its prevalence is expected to rise in coming years due to the aging population and increasing rate of obesity. The disease is caused by gradual changes to cartilage that cushions bones and joints. During aging and repetitive stress, molecules and genes in the cells of this articular cartilage change, eventually leading to the breakdown of the cartilage and the overgrowth of underlying bone, causing chronic pain and stiffness
The researchers treated young, otherwise healthy rats with osteoarthritis with viral particles containing the DNA instructions for making αKLOTHO and TGFβR2
Six weeks after the treatment, rats that had received control particles had more severe osteoarthritis in their knees, with the disease progressing from stage 2 to stage 4. However, rats that had received particles containing αKLOTHO and TGFβR2 DNA showed recovery of their cartilage: the cartilage was thicker, fewer cells were dying, and actively proliferating cells were present. These animals’ disease improved from stage 2 to stage 1, a mild form of osteoarthritis, and no negative side effects were observed
“From the very first time we tested this drug combination on just a few animals, we saw a huge improvement,” says Isabel Guillen-Guillen, also a Salk postdoctoral fellow and the paper’s co-first author. “We kept checking more animals and seeing the same encouraging results.”
“We think that this could be a viable treatment for osteoarthritis in humans,” says Pedro Guillen, director of the Clinica CEMTRO and co-corresponding author

The Complete Story: DRUG COMBO REVERSES ARTHRITIS IN RATS

Salk Institute for Biological Studies | Harvard University | Universidad Católica San Antonio de Murcia | Chinese Academy of Sciences

Go deeper with Bing News on:

Osteoarthritis

Research suggests early osteoarthritis intervention could save $1b per year
on April 27, 2021 at 3:57 pm
A lack of funding is forcing doctors to tell osteoarthritis sufferers to wait on surgery rather than speak with exercise therapists or dieticians.
Ampio Pharmaceuticals Provides Updates on Clinical Programs for Ampion™ in Osteoarthritis and COVID-19
on April 27, 2021 at 6:15 am
Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for ...
Osteoarthritis Therapeutic Market to Witness Huge Growth by 2025 | Sanofi, Horizon Therapeutics, Johnson & Johnson
on April 26, 2021 at 7:40 pm
Latest released the research study on Global Osteoarthritis Therapeutic Market, offers a detailed overview of the factors influencing the global business scope. Osteoarthritis Therapeutic Market ...
Mitochondrial DNA impact on joint damaged process in a conplastic mouse model after being surgically induced with osteoarthritis
on April 26, 2021 at 5:00 pm
It has been suggested that mitochondrial dysfunction and mtDNA variations may contribute to osteoarthritis (OA) pathogenesis. However, the causative link to support this claim is lacking. Here, we ...
Biosplice Publishes Successful Clinical Trial in Knee Osteoarthritis
on April 26, 2021 at 6:15 am
Biosplice Therapeutics, Inc. ("Biosplice"), a clinical-stage biotechnology company pioneering therapeutics based on ...

Go deeper with Google Headlines on:

Osteoarthritis

Mild Osteoarthritis: Symptoms, Diagnosis, and Treatment - Verywell Health
April 12, 2021
Modified Nanoparticles Can Stop Osteoarthritis Development - Newswise
April 13, 2021
Phospholipase A2 inhibitor–loaded micellar nanoparticles attenuate inflammation and mitigate osteoarthritis progression - Science Advances
April 7, 2021
Osteoarthritis drug pipeline rattles as FDA rejects top contender: What comes next? - Healio
April 28, 2021
Can Kinesio Tape Help with Osteoarthritis? - Health Essentials from Cleveland Clinic
April 8, 2021

Go deeper with Bing News on:

Reversing osteoarthritis

NOT REAL NEWS: A look at what didn’t happen this week
on April 30, 2021 at 10:28 am
A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked ...
Medial Knee Pain Exercises
on April 29, 2021 at 4:20 pm
Medial knee pain can be caused by several different problems. Exercises to improve flexibility and strengthen leg muscles can ease some discomfort.
'Jelly' that could renew damaged knee joints: Scientists hope jab will stimulate the growth of cartilage once injected
on April 28, 2021 at 9:10 am
Scientists hope the jab, using jelly found in donated umbilical cords, will stimulate the growth of cushioning cartilage once injected into the knees of patients with osteoarthritis.
The TLR-2/TonEBP signaling pathway regulates 29-kDa fibronectin fragment-dependent expression of matrix metalloproteinases
on April 26, 2021 at 4:42 pm
Fibronectin fragments (FN-fs), which are abundant in the synovial fluid of patients with osteoarthritis (OA), induce expression of matrix metalloproteinases (MMPs) via the toll-like receptor-2 (TLR-2) ...
Best elliptical machines: Health benefits, alternatives, and more
on April 25, 2021 at 7:00 pm
Elliptical trainers are stationary machines that simulate walking and climbing for a whole body workout. Learn more about them and some of the best models here.